Brazil surpasses half a million probable cases of dengue; SP

Brazil surpasses half a million probable cases of dengue;  SP

Brazil surpassed half a million probable cases of dengue fever, according to updated numbers released by the Ministry of Health on Monday (12). With 512,353 suspected cases registered in the first six epidemiological weeks of the year, the number is almost four times higher than the same period in 2023 (128,842).

Continues after advertising

75 deaths have already been confirmed in 2024 due to the disease and another 350 are under investigation. Minas Gerais has the highest number of probable cases, approximately 171 thousand. Next come São Paulo (83,651), Distrito Federal (64,403), Paraná (55,532), Rio de Janeiro (39,315), Goiás (31,809), Espírito Santo (14,107) and Santa Catarina (12,470).

Continues after advertising

On Thursday (8), the Ministry of Health began distributing dengue vaccines to municipalities that meet the criteria defined by the Ministry. On Monday, the São Paulo State Health Department announced that it received 79,400 doses, which will begin to be distributed to children aged 10 and 11 in the 11 municipalities in the Alto Tietê region.

In total, 521 Brazilian municipalities were selected to start vaccination against dengue. These cities make up 37 health regions considered endemic for the disease. The initial batch, with 712 thousand doses, is being sent to 315 municipalities in several units of the federation: Federal District, Goiás, Bahia, Acre, Paraíba, Rio Grande do Norte, Mato Grosso do Sul, Amazonas, São Paulo and Maranhão.

:: WHO: dengue outbreak in Brazil is part of an increase on a global scale ::

Brazil is the first country in the world to offer the vaccine in the public system. Produced by the Takeda laboratory, Qdenga was incorporated into the Unified Health System (SUS) in December last year. The Ministry of Health plans to distribute six million doses across the country.

Vaccination with Qdenga, from the Japanese pharmaceutical company Takeda, will begin with children in this age group and will progress progressively as new batches are delivered by the manufacturer. This age group has the highest rate of hospitalization for dengue among the vaccine’s target audience, aged 10 to 14.

Editing: Nicolau Soares


This news article has been translated from the original language to English by

You can visit the original source at the link below.

Original Source Link